12:00 AM
Feb 18, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Eliquis apixaban regulatory update

The Scottish Medicines Consortium recommended the use of Eliquis apixaban from Bristol-Myers and Pfizer on the National Health Service (NHS) in Scotland to prevent stroke and systemic embolism in...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >